Tang WHW - Search Results

1

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.

Demissei BG, Hubbard RA, Zhang L, Smith AM, Sheline K, McDonald C, Narayan V, Domchek SM, DeMichele A, Shah P, Clark AS, Fox K, Matro J, Bradbury AR, Knollman H, Getz KD, Armenian SH, Januzzi JL, Tang WHW, Liu P, Ky B. Demissei BG, et al. Among authors: tang whw. J Am Heart Assoc. 2020 Jan 21;9(2):e014708. doi: 10.1161/JAHA.119.014708. Epub 2020 Jan 21. J Am Heart Assoc. 2020. PMID: 31959034 Free PMC article.

2

Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.

Tang WH, Steinhubl SR, Van Lente F, Brennan D, McErlean E, Maroo A, Francis GS, Topol EJ. Tang WH, et al. Am Heart J. 2007 Jan;153(1):36-41. doi: 10.1016/j.ahj.2006.10.011. Am Heart J. 2007. PMID: 17174634

3

Using echocardiography in cardiac resynchronization therapy.

Mullens W, Tang WH, Grimm RA. Mullens W, et al. Am Heart J. 2007 Dec;154(6):1011-20. doi: 10.1016/j.ahj.2007.07.039. Epub 2007 Sep 14. Am Heart J. 2007. PMID: 18035069 Review.

4

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure.

Ky B, French B, McCloskey K, Rame JE, McIntosh E, Shahi P, Dries DL, Tang WH, Wu AH, Fang JC, Boxer R, Sweitzer NK, Levy WC, Goldberg LR, Jessup M, Cappola TP. Ky B, et al. Circ Heart Fail. 2011 Mar;4(2):180-7. doi: 10.1161/CIRCHEARTFAILURE.110.958223. Epub 2010 Dec 22. Circ Heart Fail. 2011. PMID: 21178018 Free PMC article.

5

Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure.

Tang WH, Shrestha K, Troughton RW, Borowski AG, Klein AL. Tang WH, et al. Congest Heart Fail. 2011 May-Jun;17(3):105-9. doi: 10.1111/j.1751-7133.2011.00221.x. Epub 2011 Mar 31. Congest Heart Fail. 2011. PMID: 21609382 Free article.

6

The impact of left ventricular size on response to cardiac resynchronization therapy.

Rickard J, Brennan DM, Martin DO, Hsich E, Tang WH, Lindsay BD, Starling RC, Wilkoff BL, Grimm RA. Rickard J, et al. Am Heart J. 2011 Oct;162(4):646-53. doi: 10.1016/j.ahj.2011.07.008. Epub 2011 Sep 14. Am Heart J. 2011. PMID: 21982656

7

Translating metabolomics to cardiovascular biomarkers.

Senn T, Hazen SL, Tang WH. Senn T, et al. Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):70-6. doi: 10.1016/j.pcad.2012.06.004. Prog Cardiovasc Dis. 2012. PMID: 22824112 Free PMC article. Review.

8

Prognostic value of estimated functional capacity incremental to cardiac biomarkers in stable cardiac patients.

Tang WH, Topol EJ, Fan Y, Wu Y, Cho L, Stevenson C, Ellis SG, Hazen SL. Tang WH, et al. J Am Heart Assoc. 2014 Oct 20;3(5):e000960. doi: 10.1161/JAHA.114.000960. J Am Heart Assoc. 2014. PMID: 25332177 Free PMC article.

9

Prognostic comparison of different sensitivity cardiac troponin assays in stable heart failure.

Grodin JL, Neale S, Wu Y, Hazen SL, Tang WH. Grodin JL, et al. Am J Med. 2015 Mar;128(3):276-82. doi: 10.1016/j.amjmed.2014.09.029. Epub 2014 Oct 15. Am J Med. 2015. PMID: 25447612 Free PMC article.

10

Utilizing cardiac biomarkers to detect and prevent chemotherapy-induced cardiomyopathy.

Singh D, Thakur A, Tang WH. Singh D, et al. Curr Heart Fail Rep. 2015 Jun;12(3):255-62. doi: 10.1007/s11897-015-0258-4. Curr Heart Fail Rep. 2015. PMID: 25869733 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

834 results

Search Page